Cigna Group/$CI
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Ticker
$CI
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
72,398
ISIN
US1255231003
Website
Cigna Group Metrics
BasicAdvanced
$84B
17.48
$17.99
0.45
$5.82
1.92%
Price and volume
Market cap
$84B
Beta
0.45
52-week high
$365.58
52-week low
$262.03
Average daily volume
1.8M
Dividend rate
$5.82
Financial strength
Current ratio
0.781
Quick ratio
0.648
Long term debt to equity
65.46
Total debt to equity
75.34
Dividend payout ratio (TTM)
31.35%
Interest coverage (TTM)
6.63%
Profitability
EBITDA (TTM)
11,471
Gross margin (TTM)
10.25%
Net profit margin (TTM)
1.97%
Operating margin (TTM)
3.83%
Effective tax rate (TTM)
21.04%
Revenue per employee (TTM)
$3,530,000
Management effectiveness
Return on assets (TTM)
4.03%
Return on equity (TTM)
13.21%
Valuation
Price to earnings (TTM)
17.476
Price to revenue (TTM)
0.34
Price to book
2.11
Price to tangible book (TTM)
-2.56
Price to free cash flow (TTM)
15.219
Free cash flow yield (TTM)
6.57%
Free cash flow per share (TTM)
2,065.89%
Dividend yield (TTM)
1.85%
Forward dividend yield
1.92%
Growth
Revenue change (TTM)
23.96%
Earnings per share change (TTM)
46.10%
3-year revenue growth (CAGR)
12.97%
10-year revenue growth (CAGR)
21.68%
3-year earnings per share growth (CAGR)
3.55%
10-year earnings per share growth (CAGR)
8.51%
3-year dividend per share growth (CAGR)
11.49%
10-year dividend per share growth (CAGR)
64.23%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Bulls say / Bears say
Cigna raised its full-year earnings forecast and exceeded first-quarter profit expectations, driven by strong performance in its pharmacy benefit management segment and lower-than-anticipated medical costs. (reuters.com)
The company's Evernorth Health Services unit, which includes the pharmacy benefit management business, saw a 36% increase in revenue to $52.64 billion in Q3 2024, indicating robust growth in this segment. (reuters.com)
Cigna's strategic focus on pharmacy benefit management and commercial health insurance, following the sale of its Medicare business, positions it to capitalize on growing demand in these areas. (reuters.com)
In Q4 2024, Cigna's adjusted earnings per share of $6.64 missed the consensus estimate of $7.83, reflecting challenges in meeting profit expectations. (zacks.com)
The company's medical care ratio deteriorated to 87.9% in Q4 2024, indicating higher medical costs and potential pressure on profit margins. (reuters.com)
Cigna's total medical customer base declined by 3.2% year-over-year to 19.1 million in Q4 2024, suggesting challenges in maintaining or growing its membership base. (tradingview.com)
Data summarised monthly by Lightyear AI. Last updated on 27 May 2025.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Cigna Group News
AllArticlesVideos
$CI
NaN%Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy
Business Wire·4 weeks ago
$CI
NaN%Cigna to offer $200 Wegovy, Zepbound weight-loss benefit
Reuters·1 month ago
$LLY
NaN%$CI
NaN%$NVO
NaN%Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
CNBC·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Cigna Group stock?
Cigna Group (CI) has a market cap of $84B as of June 20, 2025.
What is the P/E ratio for Cigna Group stock?
The price to earnings (P/E) ratio for Cigna Group (CI) stock is 17.48 as of June 20, 2025.
Does Cigna Group stock pay dividends?
Yes, the Cigna Group (CI) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $5.82 and the yield is 1.92%. Cigna Group has a payout ratio of 31.35% on a trailing twelve-month basis.
When is the next Cigna Group dividend payment date?
The next Cigna Group (CI) dividend payment date is unconfirmed.
What is the beta indicator for Cigna Group?
Cigna Group (CI) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
